Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arie Admon

Showing results (101-110 of 114) with videos related to

Pageof 12
Sort By:
Science Signaling|February 1, 2018
SILAC identifies LAD1 as a filamin-binding regulator of actin dynamics in response to EGF and a marker of aggressive breast tumorsLee Roth, Swati Srivastava, Moshit Lindzen, et al.
Scientific Reports|January 14, 2018
RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cellsNouar Qutob, Ikuo Masuho, Michal Alon, et al.
Scientific Reports|March 10, 2019
Author Correction: RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cellsNouar Qutob, Ikuo Masuho, Michal Alon, et al.
Cell|September 17, 2019
UVB-Induced Tumor Heterogeneity Diminishes Immune Response in MelanomaYochai Wolf, Osnat Bartok, Sushant Patkar, et al.
Cancer Discovery|September 14, 2018
Combined Analysis of Antigen Presentation and T-cell Recognition Reveals Restricted Immune Responses in MelanomaShelly Kalaora, Yochai Wolf, Tali Feferman, et al.
Cell|August 14, 2018
Urea Cycle Dysregulation Generates Clinically Relevant Genomic and Biochemical SignaturesJoo Sang Lee, Lital Adler, Hiren Karathia, et al.
The Journal of Clinical Investigation|October 15, 2021
Combined presentation and immunogenicity analysis reveals a recurrent RAS.Q61K neoantigen in melanomaAviyah Peri, Erez Greenstein, Michal Alon, et al.
Molecular & Cellular Proteomics : MCP|August 4, 2018
Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and PlasmaBracha Shraibman, Eilon Barnea, Dganit Melamed Kadosh, et al.
Molecular & Cellular Proteomics : MCP|June 3, 2019
Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and PlasmaBracha Shraibman, Eilon Barnea, Dganit Melamed Kadosh, et al.
Proteomics|August 17, 2005
Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available databaseGilbert S Omenn, David J States, Marcin Adamski, et al.
Pageof 12

Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
Science Signaling|February 1, 2018
SILAC identifies LAD1 as a filamin-binding regulator of actin dynamics in response to EGF and a marker of aggressive breast tumorsLee Roth, Swati Srivastava, Moshit Lindzen, et al.
Scientific Reports|January 14, 2018
RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cellsNouar Qutob, Ikuo Masuho, Michal Alon, et al.
Scientific Reports|March 10, 2019
Author Correction: RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cellsNouar Qutob, Ikuo Masuho, Michal Alon, et al.
Cell|September 17, 2019
UVB-Induced Tumor Heterogeneity Diminishes Immune Response in MelanomaYochai Wolf, Osnat Bartok, Sushant Patkar, et al.
Cancer Discovery|September 14, 2018
Combined Analysis of Antigen Presentation and T-cell Recognition Reveals Restricted Immune Responses in MelanomaShelly Kalaora, Yochai Wolf, Tali Feferman, et al.
Cell|August 14, 2018
Urea Cycle Dysregulation Generates Clinically Relevant Genomic and Biochemical SignaturesJoo Sang Lee, Lital Adler, Hiren Karathia, et al.
The Journal of Clinical Investigation|October 15, 2021
Combined presentation and immunogenicity analysis reveals a recurrent RAS.Q61K neoantigen in melanomaAviyah Peri, Erez Greenstein, Michal Alon, et al.
Molecular & Cellular Proteomics : MCP|August 4, 2018
Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and PlasmaBracha Shraibman, Eilon Barnea, Dganit Melamed Kadosh, et al.
Molecular & Cellular Proteomics : MCP|June 3, 2019
Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and PlasmaBracha Shraibman, Eilon Barnea, Dganit Melamed Kadosh, et al.
Proteomics|August 17, 2005
Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available databaseGilbert S Omenn, David J States, Marcin Adamski, et al.
Pageof 12